cigna8k.htm
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported) March 12,
2008
CIGNA
Corporation
(Exact
name of registrant as specified in its charter)
|
Delaware
(State
or other jurisdiction of incorporation)
|
1-08323
(Commission
File Number)
|
06-1059331
(IRS
Employer
Identification
No.)
|
Two
Liberty Place, 1601 Chestnut Street
Philadelphia, Pennsylvania
19192
(Address
of principal executive offices) (Zip Code)
Registrant's
telephone number, including area code:
(215)
761-1000
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[
] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[
] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[
] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[
] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 7.01
Regulation FD
Disclosure.
On March
12, 2008, CIGNA issued a news release to reaffirm guidance for full year
2008. The news release is attached hereto as Exhibit 99.1 and
incorporated by reference herein.
Beginning
on Thursday, March 13, 2008, and for the remainder of the week, Company
officials expect to participate in meetings and calls with investors and
analysts. During these meetings and calls, Company officials expect
to reaffirm guidance for the full year 2008, as discussed on the Company's
February 6, 2008 conference call and in the press release attached
hereto. A transcript of the February 6th call is
available at http://www.cigna.com/about_us/investor
_relations/recent_disclosures.html.
Company
officials also expect to discuss recent regulatory approvals in connection with
the acquisition of the U.S. health care business of Great-West Life &
Annuity Insurance Company and its affiliates, as further described in the press
release attached hereto.
Item
9.01 Financial
Statements and Exhibits.
(d)
Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
CIGNA
CORPORATION
|
|
|
|
|
|
Date: March
12, 2008
|
By:
|
/s/
Nicole S. Jones
|
|
|
|
Nicole
S. Jones
|
|
|
|
Corporate
Secretary and
|
|
|
|
Vice
President, Corporate and Financial
Law
|